“…Among them, carbon-based nanomaterials, such as carbon dots, carbon nanotubes, and reduced graphene oxide, have been studied as photothermal agents due to their good NIR light-responsive performance and large surface area, showing great potential in tumor treatment. − However, due to the inherent fluorescence emission properties of carbon-based nanomaterials, partial energy of irradiated light is consumed to compromise the photothermal conversion efficiency, resulting in low photothermal performance and unsatisfactory photothermal therapeutic effect. − In addition, conventional PTT mainly uses NIR light in the first biowindow (NIR-I, 700–900 nm), which has drawbacks such as poor tissue penetration depth and low maximum permissible exposure (MPE, 0.33 W/cm 2 for 808 nm) that seriously hinder their in vivo applications. − In contrast, NIR light in the second biowindow (NIR-II, 1000–1700 nm) displays deeper tissue penetration and higher MPE (1 W/cm 2 for 1064 nm). − Therefore, constructing carbon-based nanomaterials with minimized fluorescence emission property and good NIR-II light-responsive capacity holds great promise for achieving efficient PTT against tumors.…”